A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples